The global cell and gene therapy biomanufacturing market is estimated to reach $29.76 billion in 2031, reveals the premium market intelligence study.
Research and Intelligence
The global cell and gene therapy biomanufacturing market is estimated to reach $29.76 billion in 2031, reveals the premium market intelligence study.